Inovio Pharmaceuticals
INO
INO
183 hedge funds and large institutions have $197M invested in Inovio Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 57 increasing their positions, 49 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.38% more ownership
Funds ownership: 3.88% → 4.25% (+0.38%)
2% less capital invested
Capital invested by funds: $201M → $197M (-$3.67M)
Holders
183
Holding in Top 10
–
Calls
$2.24M
Puts
$1.89M
Top Buyers
| 1 | +$8.5M | |
| 2 | +$3.46M | |
| 3 | +$2.71M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.59M |
| 5 |
D.E. Shaw & Co
New York
|
+$1.43M |
Top Sellers
| 1 | -$2.3M | |
| 2 | -$1.48M | |
| 3 | -$1.46M | |
| 4 |
Citigroup
New York
|
-$1.3M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.29M |